ShareValue scores for 0QHL.LSE: Valuation 50, Quality 48, Growth 50, Health 48.

0QHL.LSE
LSE

Corbion NV

£0.20(+2.21%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
50
Fair Value
Price vs Value
Quality
48
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
64
Bullish
Price Trend

Company Details

About

Corbion N.V. provides lactic acid and lactic acid derivatives, food preservation solutions, functional blends, and algae ingredients in the Netherlands, the United States, Asia, rest of North Americas, the rest of Europe, the Middle East, and Africa. It operates through Functional Ingredients & Solutions, and Health & Nutrition segments. The company offers acidification, color retention, decontamination, food safety and preservation, freshness and shelf life, health and nutrition, strengthening conditioning, and taste and texture food solutions; Purasorb R&D, a solution that offers a range of custom synthesis options; biochemical specialties solutions, such as solvency, antimicrobial, moisturization, and pharma; and algae ingredients solutions, including replacing fish oil and sustainable omega-3 sourcing. It also provides food antioxidants, fermentation and preservation ingredients, flavors, fortification, and lactic acid lactates and derivatives; chemical products, such as agrochemicals, safe solvents, polymer additives, and functional ingredients for other chemical industries; bioplastic products; pharma products; and personal care products, including skin acre, hair care, rinse-off, moisturization, skin lightening, anti-aging and personal care solutions, oral health, natural pH adjustment, emulsifiers and surfactants, and antimicrobial. In addition, the company offers Puralact B3, a resin formulator for coatings and adhesives; Purasolv, a solvent for supporting sustainable production of healthier and stronger crops; Purasolv BL, a green solution; and AlgaVia, culinary algae oils. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. Corbion N.V. has agreement to collaborate with BRAIN Biotech AG develop novel biobased antimicrobial compounds and its derivatives. The company was formerly known as CSM N.V. and changed its n

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026